scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

scPharmaceuticals (Nasdaq: SCPH), a pharmaceutical company focused on cardiorenal healthcare innovations, has scheduled its Fourth Quarter and Full Year 2024 Financial Results announcement for Wednesday, March 19, 2025. The company will host a conference call and audio webcast at 4:30 p.m. ET following market close.

Management will present financial results and provide a business update during the call. Investors and interested parties can access the event through a direct registration link, with both live webcast and replay options available on the company's website under the Investor Relations section.

03/12/2025 - 04:01 PM

Management to host conference call and webcast, after-market on March 19, 2025, at 4:30 p.m. ET

BURLINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, March 19, 2025, to discuss the financial results for the fourth quarter and full year 2024, and provide a business update.

Registration and access for the conference call can be completed through this direct registration link.

The live webcast and replay of the conference call can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
At scPharmaceuticals, we are powered by passion, driven by patient care. Our Mission is focused on advancing cardiorenal care through innovative, integrated treatments that address unmet patient needs.

Our goal is to become the foremost advocate for patient-centric cardiorenal care, driving global health improvements through specialized, multidisciplinary approaches. scPharmaceuticals is expanding its reach, offering integrated therapies and products that address diverse healthcare needs and potentially improve the lives of our patients. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com

Investors:
Nick Colangelo
Gilmartin Group, 339-225-1047
Nick@GilmartinIR.com

FAQ

When will SCPH release its Q4 and Full Year 2024 earnings?

scPharmaceuticals will release its Q4 and Full Year 2024 earnings on Wednesday, March 19, 2025, after market close.

What time is SCPH's Q4 2024 earnings call scheduled for?

The earnings conference call and webcast is scheduled for 4:30 p.m. ET on Wednesday, March 19, 2025.

How can investors access SCPH's Q4 2024 earnings call?

Investors can access the call through a direct registration link or view the webcast on scPharmaceuticals' website under the Investor Relations section.